Which of the following treatments for menorrhagia is not supported by evidence?
## Core Concept
Menorrhagia is a condition characterized by abnormally heavy or prolonged menstrual bleeding. Treatments aim to reduce menstrual blood loss, alleviate symptoms, and improve quality of life. Various medical and surgical options are available.
## Why the Correct Answer is Right
Tranexamic acid, a tranexamic acid is an antifibrinolytic agent that works by inhibiting plasminogen activation to plasmin, thereby preventing fibrin clot breakdown. It has strong evidence supporting its efficacy in reducing menstrual blood loss in patients with menorrhagia.
## Why Each Wrong Option is Incorrect
* **Option A:** Tranexamic acid is supported by evidence; it's a first-line treatment for menorrhagia.
* **Option B:** NSAIDs (Nonsteroidal anti-inflammatory drugs) are also supported by evidence as they reduce prostaglandin production, which in turn decreases menstrual blood flow.
* **Option C:** Combined oral contraceptives can help regulate menstrual cycles and reduce bleeding, making them a supported treatment option.
* **Option D:** While the specifics of option D are not provided, given that tranexamic acid, NSAIDs, and combined oral contraceptives are all evidence-based treatments, the option that does not belong would lack substantial evidence.
## Clinical Pearl / High-Yield Fact
A key point to remember is that tranexamic acid is particularly useful for acute management of heavy menstrual bleeding and has a relatively good safety profile. It's also worth noting that the effectiveness of treatments can vary between individuals, making a trial of different options sometimes necessary.
## Correct Answer: D.